🔎 Trials Near Me

Inicio › Obesidad › Florida › Miami

Ensayos clínicos de Obesidad en Miami, FL

27 estudios para Obesidad buscan participantes en centros de Miami y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.

Texto oficial del estudio (inglés)

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

ReclutandoFase 3
  • PharmaDev Clinical Research Institute LLC, Miami
Edades de 18 en adelante · Todos los sexos · Actualizado el 28 sept 2026 · NCT07668414

Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D

ReclutandoFase 1
  • Clinical Pharmacology of Miami, Miami
Edades de 18 a 65 · Todos los sexos · Actualizado el 28 sept 2026 · NCT07399678

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

ReclutandoFase 3
  • Research Associates of South Florida - Miami - Southwest 8th Street, Miami
  • Gastro Health Research - Miami, Miami
Edades de 18 a 70 · Todos los sexos · Actualizado el 24 sept 2026 · NCT06937099

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

ReclutandoFase 3
  • Research Associates of South Florida - Miami - Southwest 8th Street, Miami
  • Gastro Health Research - Miami, Miami
Edades de 18 a 70 · Todos los sexos · Actualizado el 24 sept 2026 · NCT06937086

A Study of Tirzepatide (LY3298176) in Participants With Type 1 Diabetes Mellitus and Overweight or Obesity

ReclutandoFase 1
  • Clinical Pharmacology of Miami, Miami
Edades de 18 a 70 · Todos los sexos · Actualizado el 23 sept 2026 · NCT07803744

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

ReclutandoFase 3
  • BioMed Research & Medical Center, Miami
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07321886

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

ReclutandoFase 3
  • Finlay Medical Research, Miami
  • Suncoast Research Group LLC, Miami
  • New Horizon Research Center, Miami
Edades de 45 a 99 · Todos los sexos · Actualizado el 22 sept 2026 · NCT07037433

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

ReclutandoFase 3
  • Flourish Research Acquisition, LLC dba Flourish Research - North Miami, Miami
  • New Horizon Research Center, Miami
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07282600

A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

ReclutandoFase 3
  • Flourish Research - Miami, LLC, Miami
  • PharmaDev Clinical Research Institute, LLC, Miami
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07369011

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

ReclutandoFase 3
  • New Horizon Research Center, Miami
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07392190

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

ReclutandoFase 2
  • New Horizon Research Center, Miami
Edades de 18 a 75 · Todos los sexos · Actualizado el 22 sept 2026 · NCT07589608

AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

ReclutandoFase 3
  • PharmaDev Clinical Research Institute LLC, Miami
Edades de 18 en adelante · Todos los sexos · Actualizado el 11 sept 2026 · NCT07571005

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

ReclutandoFase 3Se aceptan voluntarios sanos
  • ACCOMPLISH-2 Research Site, Miami
Edades de 18 a 79 · Todos los sexos · Actualizado el 11 sept 2026 · NCT07654374

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

ReclutandoFase 2
  • New Horizon Research Center, Miami
Edades de 18 a 75 · Todos los sexos · Actualizado el 8 sept 2026 · NCT06143956

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

ReclutandoFase 3
  • Optimus U Corporation, Miami
  • Research Institute of South Florida, Miami
Edades de 18 a 99 · Todos los sexos · Actualizado el 3 sept 2026 · NCT07684235

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

ReclutandoFase 3
  • Kailera Clinical Site, Miami
Edades de 18 en adelante · Todos los sexos · Actualizado el 3 sept 2026 · NCT07284901

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

ReclutandoFase 3
  • Optimus U Corporation, Miami
Edades de 18 a 99 · Todos los sexos · Actualizado el 3 sept 2026 · NCT07684144

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

ReclutandoFase 3
  • New Horizon Research Center, Miami
  • Research Institute of South Florida, Miami
Edades de 18 a 99 · Todos los sexos · Actualizado el 27 ago 2026 · NCT07575399

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

ReclutandoFase 3
  • Total Research Group LLC, Miami
  • Infinite Clinical Research, Miami
  • Future Life Clinical Trials, Miami
Edades de 18 en adelante · Todos los sexos · Actualizado el 18 ago 2026 · NCT07567001

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

ReclutandoFase 3
  • ACCOMPLISH-1 Research Site, Miami
Edades de 18 a 79 · Todos los sexos · Actualizado el 10 ago 2026 · NCT07654361

First in Human Study in Subjects With Obesity, But Otherwise Healthy

ReclutandoFase 1
  • Clinical Pharmacology of Miami, LLC, Miami
Edades de 18 a 65 · Todos los sexos · Actualizado el 9 abr 2026 · NCT06252220

Efficacy Trial of Healthy Together ("Juntos")

ReclutandoSe aceptan voluntarios sanos
  • University of Miami, Miami
Edades de 12 a 15 · Todos los sexos · Actualizado el 23 mar 2026 · NCT06489262

With Love, Grandma ("Con Cariño, Abuelita") Pilot Study

Reclutando
  • University of Miami, Miami
Edades de 21 en adelante · Mujeres · Actualizado el 25 feb 2026 · NCT05721976

Community Park-Based Programs for Health Promotion: The Fit2Lead Prospective Cohort Study

ReclutandoEstudio observacionalSe aceptan voluntarios sanos
  • Miami-Dade County Parks, Recreation and Open Spaces Department, Miami
Edades de 12 a 17 · Todos los sexos · Actualizado el 10 sept 2025 · NCT06596265

Community Park-Based Programs for Health Promotion: Active Older Adults Prospective Cohort Study

ReclutandoEstudio observacionalSe aceptan voluntarios sanos
  • Miami-Dade County Parks, Recreation and Open Spaces Department, Miami
Edades de 50 a 95 · Todos los sexos · Actualizado el 4 sept 2025 · NCT06604650

Community Park-Based Programs for Health Promotion: Fit2Play Prospective Cohort Study

ReclutandoEstudio observacionalSe aceptan voluntarios sanos
  • Miami-Dade County Parks, Recreation and Open Spaces Department, Miami
Edades de 6 a 14 · Todos los sexos · Actualizado el 4 sept 2025 · NCT06595251

RESET System Pivotal Trial (Rev F)

Reclutando
  • University of Miami Hospital, Miami
Edades de 22 a 65 · Todos los sexos · Actualizado el 18 jul 2024 · NCT04101669

Más información sobre Obesidad en MedlinePlus

Ensayos de Obesidad en otras ciudades

Otros estudios en Miami

De ClinicalTrials.gov, datos obtenidos el 29 sept 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.